CHANGE OF HOSPITAL DESTINATION

JAK Inhibitors for Treatment of Psoriasis, Ankylosing Spondylitis, & Multiple Sclerosis. $ 244,479.25 Diatherix Laboratories, Inc. Disease Diagnostic Panel Development Utilizing the TEM-PCR Method. $ 244,479.25 EGEN INC. EGEN-001 in Platinum-Resistant Ovarian Cancer. $ 244,479.25 EGEN, INC. EGEN TheraSilence. $ 244,479.25 iCubate, Inc ................
................